BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24598796)

  • 41. Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.
    Chen Q; Zheng T; Lan Q; Lerro C; Zhao N; Qin Q; Hu X; Huang H; Liang J; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1332-5. PubMed ID: 23640258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia.
    Setiawan VW; Schumacher F; Prescott J; Haessler J; Malinowski J; Wentzensen N; Yang H; Chanock S; Brinton L; Hartge P; Lissowska J; Park SL; Cheng I; Bush WS; Crawford DC; Ursin G; Horn-Ross P; Bernstein L; Lu L; Risch H; Yu H; Sakoda LC; Doherty J; Chen C; Jackson R; Yasmeen S; Cote M; Kocarnik JM; Peters U; Kraft P; De Vivo I; Haiman CA; Kooperberg C; Le Marchand L
    Carcinogenesis; 2014 Sep; 35(9):2068-73. PubMed ID: 24832084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.
    Zhang Y; Xia ZG; Zhu JH; Chen MB; Wang TM; Shen WX; He J
    Mol Genet Genomics; 2015 Dec; 290(6):2063-73. PubMed ID: 25977148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
    Nieters A; Conde L; Slager SL; Brooks-Wilson A; Morton L; Skibola DR; Novak AJ; Riby J; Ansell SM; Halperin E; Shanafelt TD; Agana L; Wang AH; De Roos AJ; Severson RK; Cozen W; Spinelli J; Butterbach K; Becker N; de Sanjose S; Benavente Y; Cocco P; Staines A; Maynadié M; Foretova L; Boffetta P; Brennan P; Lan Q; Zhang Y; Zheng T; Purdue M; Armstrong B; Kricker A; Vajdic CM; Grulich A; Smith MT; Bracci PM; Chanock SJ; Hartge P; Cerhan JR; Wang SS; Rothman N; Skibola CF
    Blood; 2012 Nov; 120(23):4645-8. PubMed ID: 23047821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.
    Skibola CF; Bracci PM; Halperin E; Conde L; Craig DW; Agana L; Iyadurai K; Becker N; Brooks-Wilson A; Curry JD; Spinelli JJ; Holly EA; Riby J; Zhang L; Nieters A; Smith MT; Brown KM
    Nat Genet; 2009 Aug; 41(8):873-5. PubMed ID: 19620980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
    Shen M; Zheng T; Lan Q; Zhang Y; Zahm SH; Wang SS; Holford TR; Leaderer B; Yeager M; Welch R; Kang D; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S; Rothman N
    Hum Genet; 2006 Jul; 119(6):659-68. PubMed ID: 16738949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
    Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
    Tawfeek GA; Alhassanin S
    Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.
    Moore A; Machiela MJ; Machado M; Wang SS; Kane E; Slager SL; Zhou W; Carrington M; Lan Q; Milne RL; Birmann BM; Adami HO; Albanes D; Arslan AA; Becker N; Benavente Y; Bisanzi S; Boffetta P; Bracci PM; Brennan P; Brooks-Wilson AR; Canzian F; Caporaso N; Clavel J; Cocco P; Conde L; Cox DG; Cozen W; Curtin K; De Vivo I; de Sanjose S; Foretova L; Gapstur SM; Ghesquières H; Giles GG; Glenn M; Glimelius B; Gao C; Habermann TM; Hjalgrim H; Jackson RD; Liebow M; Link BK; Maynadie M; McKay J; Melbye M; Miligi L; Molina TJ; Monnereau A; Nieters A; North KE; Offit K; Patel AV; Piro S; Ravichandran V; Riboli E; Salles G; Severson RK; Skibola CF; Smedby KE; Southey MC; Spinelli JJ; Staines A; Stewart C; Teras LR; Tinker LF; Travis RC; Vajdic CM; Vermeulen RCH; Vijai J; Weiderpass E; Weinstein S; Doo NW; Zhang Y; Zheng T; Chanock SJ; Rothman N; Cerhan JR; Dean M; Camp NJ; Yeager M; Berndt SI
    J Transl Genet Genom; 2021; 5():200-217. PubMed ID: 34622145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.
    Ten LC; Chin YM; Tai MC; Chin EF; Lim YY; Suthandiram S; Chang KM; Ong TC; Bee PC; Mohamed Z; Gan GG; Ng CC
    Sci Rep; 2017 Jan; 7():41400. PubMed ID: 28139690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
    Cao C; Liu S; Lou SF; Liu T
    Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
    Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
    Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.
    Chiu YH; Bertrand KA; Zhang S; Laden F; Epstein MM; Rosner BA; Chiuve S; Campos H; Giovannucci EL; Chavarro JE; Birmann BM
    Int J Cancer; 2018 Oct; 143(8):1914-1922. PubMed ID: 29756258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial predisposition and genetic risk factors for lymphoma.
    Cerhan JR; Slager SL
    Blood; 2015 Nov; 126(20):2265-73. PubMed ID: 26405224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
    Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
    Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
    Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.
    Zhong C; Gragert L; Maiers M; Hill BT; Garcia-Gomez J; Gendzekhadze K; Senitzer D; Song J; Weisenburger D; Goldstein L; Wang SS
    Leuk Lymphoma; 2019 Dec; 60(12):2899-2908. PubMed ID: 31215275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.